Accenture and Roche have entered into an exclusive, multi-year collaborative services agreement, under which Accenture will provide digital data integration services to Roche’s NAVIFY Tumor Board solution.
A tumor board is a meeting in which multi-disciplinary healthcare teams review and discuss individual cancer patient cases and available treatment options. The cloud-based NAVIFY Tumor Board solution streamlines and standardizes this process by aggregating relevant patient data from disparate IT systems into a software solution that fosters efficient team collaboration, reduces errors, and gives the care team more time to evaluate individual patient cases.
The data integration capabilities Accenture provides will allow Roche to integrate patient data between hospitals and the NAVIFY Tumor Board solution to support clinicians in arriving at the best possible treatment decisions for their patients.
“Tumor board coordination is labor intensive and time consuming for healthcare providers,” Tim M. Jaeger, Global Head of Diagnostics Information Solutions for Roche, said in a statement. “Accenture’s global scale, deep digital expertise, and innovation capabilities in the healthcare and life sciences industries allows Roche to continue our focus on delivering workflow and decision support solutions to customers and improving patient outcomes.”
Andrea Brückner, who leads Accenture’s Life Sciences practice in Europe, added: “By providing data integration services to the NAVIFY Tumor Board solution, we aim to ensure that all available data is used to accelerate and optimize treatment decisions for cancer patients.”
The NAVIFY Tumor Board solution fundamentally changes the way tumor board meetings are organized and conducted with the goal of fostering collaboration on patient treatment decisions. It is currently available in the US, UK, Germany, Spain, Sweden, Switzerland, and the Netherlands.